Search filters

Filters
Clear All

Phase

  • 1
  • 2
  • 4
  • 1
  • 7
  • 1
  • 5
  • 22
  • 6
  • 1
  • 5
  • 16

Found 22 Cancer Treatment trials

A listing of Cancer Treatment medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
18 years or above
All genders
Phase 1
Interventional
This study investigates the safety and effects of an investigational medication in people with advanced solid tumors that have a specific gene change called KRAS G12D mutation. The purpose of this study is to learn how the investigational medication works when given alone or with other cancer treatments.Participants in the …
18 years or above
All genders
Interventional
This study investigates the effectiveness of the "Just ASK" training program in enhancing discussions about breast cancer clinical trials between healthcare providers and patients. The purpose of this study is to evaluate if the training can increase the frequency and quality of these discussions, which are crucial for patient enrollment …
UPCC 11125: The MILES Study: A Mixed-Methods Metabolomics Investigation of Lifestyle and Energy Balance During Breast Cancer Survivorship
18 years or above
Female
Interventional
This study investigates breast cancer. It focuses on understanding lifestyle and energy balance in women during early treatment stages.The study evaluates dietary quality and physical activity over time. It also looks at how these factors can support healthy behaviors in patients.Who can participate: Adult women aged 18 years or older …
18 years or above
All genders
Phase 2/3
Interventional
This study investigates treatments for non-small cell lung cancer (NSCLC) by using a method called genomic screening. The purpose of this study is to determine which type of cancer trait, known as a biomarker, a participant has. This information helps assign participants to different sub-studies within a larger protocol called …
18 years - 50 years
All genders
Phase 3
Interventional
This study investigates digital mindfulness-based interventions for younger breast cancer survivors who experience elevated depressive symptoms. The purpose of this study is to compare two different digital approaches: one that is live and instructor-led via Zoom, and another that is self-paced and app-based. Participants are breast cancer survivors diagnosed at …
99 years or below
All genders
To examine the feasibility of recruiting and evaluate before and after outcomes of breast cancer survivors to undergo a patient-centered, interdisciplinary, multimodal comprehensive rehabilitation program aimed at addressing musculoskeletal, fatigue and cognitive sequelae of their cancer treatment (chemotherapy and/or endocrine therapy). Multifactorial Memory Questionnaire APT II- Attention Process Training Questionnaire …
99 years or below
All genders
Lynch syndrome (LS) is a cancer predisposition syndrome that results from a pathogenic germline mutation in one of five genes, including MLH1, MSH2, MSH6, PMS2, and EPCAM, which are involved in DNA mismatch repair (MMR). Individuals with Lynch syndrome develop cancer at a substantially higher rate than individuals without LS …
All genders
Phase 2
Interventional
This study investigates how genetic testing can guide cancer treatment choices for patients with advanced solid tumors. The purpose is to use the genetic information from patients' tumor cells to match them with investigational combination therapies that target specific genetic mutations. This approach aims to control tumor growth and improve …
99 years or below
All genders
We propose an iterative approach to develop and pilot test a new mHealth behavioral intervention for AET adherence that is culturally tailored to Black breast cancer survivors. We will first use qualitative methods informed by Black breast cancer survivors to develop a blueprint of the intervention (Aim 1). We will …
12 years or above
All genders
Phase 1/2
Interventional
This study investigates the safety, tolerability, and effects of an investigational medication in individuals with blood cancers that have not responded to previous treatments. The purpose of this study is to determine how well the investigational medication works when used alone or in combination with other anticancer agents. Participants will …
1 - 10 of 22